UMP Healthcare Holdings Limited (HKG:0722)
0.4650
+0.0100 (2.20%)
Jun 16, 2025, 3:05 PM HKT
UMP Healthcare Holdings Revenue
UMP Healthcare Holdings had revenue of 371.46M HKD in the half year ending December 31, 2024, with 1.69% growth. This brings the company's revenue in the last twelve months to 745.41M, up 0.93% year-over-year. In the fiscal year ending June 30, 2024, UMP Healthcare Holdings had annual revenue of 750.01M with 3.06% growth.
Revenue (ttm)
745.41M
Revenue Growth
+0.93%
P/S Ratio
0.49
Revenue / Employee
1.65M
Employees
551
Market Cap
363.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 750.01M | 22.26M | 3.06% |
Jun 30, 2023 | 727.75M | 61.55M | 9.24% |
Jun 30, 2022 | 666.20M | 49.04M | 7.95% |
Jun 30, 2021 | 617.16M | 58.35M | 10.44% |
Jun 30, 2020 | 558.81M | -11.23M | -1.97% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |
Sino Biopharmaceutical | 30.72B |
Akeso | 2.26B |